O. Grosu, N. Yamani, Nathaniel M. Schuster, J. Sreedharan, Joelle Berchan, M. Pradeep, Anis Riahi, Pravin Thomas
{"title":"抗cgrp单克隆抗体对发作性和慢性偏头痛患者治疗3个月后偏头痛特征、残疾、影响和生活质量的影响:一项系统回顾和荟萃分析","authors":"O. Grosu, N. Yamani, Nathaniel M. Schuster, J. Sreedharan, Joelle Berchan, M. Pradeep, Anis Riahi, Pravin Thomas","doi":"10.52828/hmc.v1i2.1_cgrp","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":149217,"journal":{"name":"Headache Medicine Connections","volume":"36 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of Anti-CGRP monoclonal antibodies for episodic and chronic migraine on migraine characteristics, disability, impact and quality of life beyond 3 months of treatment: A Systematic review and Meta-analysis\",\"authors\":\"O. Grosu, N. Yamani, Nathaniel M. Schuster, J. Sreedharan, Joelle Berchan, M. Pradeep, Anis Riahi, Pravin Thomas\",\"doi\":\"10.52828/hmc.v1i2.1_cgrp\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":149217,\"journal\":{\"name\":\"Headache Medicine Connections\",\"volume\":\"36 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Headache Medicine Connections\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52828/hmc.v1i2.1_cgrp\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Headache Medicine Connections","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52828/hmc.v1i2.1_cgrp","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Effects of Anti-CGRP monoclonal antibodies for episodic and chronic migraine on migraine characteristics, disability, impact and quality of life beyond 3 months of treatment: A Systematic review and Meta-analysis